In the News

Share
1666 News Items found
In the Clinic
Ingrid Adams speaks with nurse practitioner Virginia Ferreira.
FDA Approves New Drug for Non-Small Cell Lung Cancer With ROS1 Fusions
Learn more about the new FDA-approved drug repotrectinib (AugtyroTM), which targets ROS1 fusions in lung cancer and other cancer types.
A person reclining in a chair donates blood
Donating Bone Marrow and Stem Cells: The Process and What To Expect
Learn everything you need to know about donating bone marrow or blood stem cells and why it’s important to join a public registry.
Close-up of hand holding glass of red wine.
Does Drinking Alcohol Cause Cancer? Learn About the Risks
Learn more about the link between drinking alcohol and the risk of developing cancer.
Looking through a microscope at a tissue sample
MSK Research Highlights, December 29, 2023
New MSK research developed CAR T cells that target two acute myeloid leukemia-specific antigens; shed new light on a genetic element called LINE-1, opening the door to new treatments; identified a key regulator of blood stem cell fate; and found an immunotherapy technique using antibodies that target CD47 shows promise in mice.
Christine Mayr
Location, Location, Location: The Hidden Power of Intracellular Neighborhoods
New findings provide details about the hidden organization of the cytoplasm, showing it makes a big difference where in that cellular broth that messenger RNA (mRNA) get translated into proteins. The findings hold promise for increasing or altering the production of proteins in mRNA vaccines and therapies.
In the Clinic
MSK radiation oncologist and neuroblastoma expert Suzanne Wolden with a patient
Reduced Radiation for Neuroblastoma Could Lessen Children’s Side Effects Later
Learn how MSK doctors are exploring the use of less radiation in neuroblastoma treatment so children can avoid side effects.
a researcher holds a sign reading "Proud to be an MSK scientist"
Top Cancer Research Advances at MSK in 2023
Researchers at MSK pioneered many discoveries in 2023. Read about some of the most important findings.
Feature
Dr. Christopher Klebanoff
A New Type of Immunotherapy: MSK’s Christopher Klebanoff Is Fighting Cancer Cells From the Inside Out With T Cell Receptor (TCR) Therapy
Learn how MSK physician-scientist Christopher Klebanoff is working to bring immunotherapy to more patients, especially those with solid tumors.
MSK endometrial cancer specialists are seen: gynecological surgeon Carol Brown, MD; Carol Aghajanian, MD, Chief of the Gynecological  Medical Oncology Service; medical oncologist Ying Liu, MD, MPH; and molecular geneticist Britta Weigelt, PhD.
Endometrial Cancer: New Insights Into a Deadly Disparity
Learn about new insights into endometrial cancer discovered by MSK experts, including why the growing rates of this cancer are even more dangerous for Black women.
Feature
Alicia Kalogeropoulos with her husband, Alex, at the beach.
Top Cancer Treatment Advances at MSK in 2023
Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in many types of cancer treatment for patients in 2023. Read about some of the most important developments over the past year.
Feature
Dr. Miguel-Angel Perales
8 Reasons Why MSK Is a Leader in Stem Cell and Bone Marrow Transplants
The year 2023 marks the 50th anniversary of the first-ever transplant of bone marrow from a donor to a patient who was not related, which was performed at MSK. Here, Dr. Miguel-Angel Perales explains why MSK has continued to be a leader in the field of transplantation.
Patient receiving stereotactic body radiation therapy at Memorial Sloan Kettering Cancer Center.
Ablative Radiotherapy Controls Resistant Non-Small Cell Lung Cancer in Clinical Trial
Learn how highly focused, intense radiation can stop lung cancer from growing after it has spread to a small number of sites.
In the Clinic
Dr. Lorenzo Falchi
Blood Test To Identify Which Large B Cell Lymphoma Patients Are Candidates for Glofitamab Shows Promise in Clinical Trial
Learn about results from a clinical trial that found blood tests can help predict which patients with large B cell lymphoma are likely to benefit from the targeted therapy glofitamab (Columvi).
In the Clinic
Anne and Robert Schmiedel
New Treatment Results for Follicular Lymphoma Clinical Trial Presented at ASH 2023
A clinical trial of the targeted therapy mosunetuzumab (Lunsumio) has found this drug may help patients with follicular lymphoma avoid chemotherapy. Learn more about how it benefited patients who had not yet received other treatments for their lymphoma.
Omar Abdel-Wahab and Salima Benbarche
MSK’s Omar Abdel-Wahab Honored for Research Targeting Blood Cancers
MSK physician-scientist Dr. Omar Abdel-Wahab, is being honored at the 2023 American Society of Hematology (ASH) Annual Meeting with the William Dameshek Prize, which recognizes individuals who have made outstanding contributions to the field of hematology.
Suleika Jaouad is seen in the hallway of MSK with her husband Jon Batiste.
Living Life to the Fullest During Cancer: ‘American Symphony’ Documentary
Learn about life lessons during cancer in the acclaimed documentary "American Symphony," which follows Suleika Jaouad and Jon Batiste’s journey during her bone marrow transplant at Memorial Sloan Kettering.
Dana and John Avellino
FDA Approves Nirogacestat, the First-Ever Targeted Therapy for Desmoid Tumors
The FDA has approved nirogacestat (OgsiveoTM), a targeted therapy for desmoid tumors. A recent phase 3 clinical trial found that the drug significantly shrank desmoid tumors in 41% of patients. Desmoid tumors (also known as aggressive fibromatosis) are a rare type of soft tissue tumor.
scientists working in the lab
MSK Research Highlights, November 27, 2023
New MSK research finds both acupuncture and massage can benefit those with cancer-related pain; investigates relapse after CAR T cell therapy for multiple-myeloma; and showcases the power of open-source science to develop medicines against COVID-19 and other pandemics.
Feature
MSK melanoma expert James Smithy, MD
New Treatments Improving Prognosis for Stage 4 Melanoma Patients
In recent years, advanced melanoma (a type of skin cancer) has been transformed from a disease that was almost always fatal to one that often can be br...
scientific image of mouse lung cancer cells
Lung Cancer Cells’ ‘Memories’ Suggest New Strategy For Improving Treatment
Research from the lab of cancer biologist Tuomas Tammela shows that some lung cancer cells retain a “memory” of the healthy cell where they came from — one that might be exploited to make an emerging type of lung cancer treatment called KRAS inhibition more effective.